Global Antibiotic Resistance Market

Global Antibiotic Resistance Market Size, Trends & Analysis - Forecasts to 2026 By Disease (Complicated Urinary Tract Infection (cUTI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community Acquired Bacterial Pneumonia (CABP), Complicated Intra-Abdominal Infections (cIAI), Blood Stream Infections (BSI), Clostridium difficile infections (CDI)), By End User (Hospitals & Clinics, Research Organizations, Others), By Drug Class (Lipoglycopeptides, Oxazolidinones, Cephalosporins, Tetracyclines, Combination, Others), By Pathogen (Acinetobacter baumannii (Carbapenem-Resistant), Pseudomonas aeruginosa (Carbapenem-Resistant), Staphylococcus Aureus (Methicillin-Resistant), E. coli/K. pneumoniae (Carbapenem-Resistant), Streptococcus pneumoniae (Penicillin-Non-Susceptible), Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant), Enterococcus faecium (Vancomycin-Resistant), Haemophilus Influenzae (Ampicillin-Resistant)), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf

Antibiotic Resistance Market: Insights

The global antibiotic resistance market is expected to generate revenue amounting to USD 9,380.29 million in 2020, and is projected to reach to USD 13,531.50 million by 2026, growing at a CAGR of 6.30% over the forecast period. Growing population along with prevalence of chronic diseases across the globe is driving the market growth. Presence of multi-national manufacturers, high burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens are also some of the major factors expected to propel the market growth during the forecast period. 

Increase in the global initiatives to control drug-resistance along with growing number of antibiotics resistance infections in the under developed nations is also driving the market growth for antibiotic resistance. Growing usage of antibiotics across various regions including North America, Europe, Asia Pacific, and Central & South America is further projected to propel the market growth of antibiotic resistance. However, the high treatment cost of is likely to hamper the market growth during the forecast period. 

Antibiotic Resistance Market: By Disease

On the basis of disease, the global antibiotic resistance market is segmented into complicated urinary tract infection (CUTI), complicated intra-abdominal infections (CIAI), blood stream infections (BSI), clostridium difficile infections (cdi), acute bacterial skin and skin structure infections (ABSSSI), hospital acquired bacterial pneumonia/ventilator (HABP/VABP), and community acquired bacterial pneumonia (CABP). The complicated urinary tract infection (CUIT) segment was estimated to hold the largest market share during the forecast period. The limited treatment alternatives for complicated urinary tract infections (CUIT) is driving the market growth for the segment. Complicated urinary tract infection happens in individuals with genitourinary tract functional or structural abnormalities. Complicated urinary tract infections (cUTI) are common bacterial infections and a frequent source of primary infection in patients presenting with severe sepsis or septic shock.

Antibiotic Resistance Market: By Pathogen

On the basis of pathogen, the market is segmented into acinetobacter baumannii (carbapenem-resistant), pseudomonas aeruginosa (carbapenem-resistant), staphylococcus aureus (methicillin-resistant), e. coli/k. pneumoniae (carbapenem-resistant), streptococcus pneumoniae (penicillin-non-susceptible), clostridium difficile (cephalosporin-resistant, tetracycline-resistant), enterococcus faecium (vancomycin-resistant), and haemophilus influenzae (ampicillin-resistant). The e. coli/k. pneumoniae (carbapenem-resistant) was estimated to hold the largest market share and is projected to grow at the highest CAGR during the forecast period. E. Coli and K. Pneumoniae have been studied for the determination of the molecular resistance mechanism. It focuses on antibiotic resistance in seven specific bacteria responsible for common serious diseases such as infections with the bloodstream, diarrhea, pneumonia, UTIs, and gonorrhea, among others.

Antibiotic Resistance Market: By Drug Class

On the basis of drug class, the market is segmented into oxazolidinones, lipoglycopeptides, tetracyclines, cephalosporins, and combination among others. The cephalosporins segment was estimated to hold the largest market share during the forecast period. Cephalosporins are a large group of antibiotics that belong to a class known as beta-lactam antibiotics. Cephalosporins are bactericidal and function similarly to penicillins. These drugs are used to treat bacterial infections including ear infections, pneumonia, skin infections, and kidney infections, among others. The combination segment is expected to grow at a high CAGR during the forecast period. A combination drug or a mixture of fixed doses (FDC) is a drug that contains two or more active ingredients incorporated in a single dosage type. They are widely used in human and veterinary medicine, among others.

Antibiotic Resistance Market: By End User

Based on the end-user, the antibiotic resistance is segmented into hospitals & clinics, and research organizations, among others. The hospitals & clinics segment is anticipated to hold the largest market share in terms of revenue during the forecast period.

Antibiotic Resistance Market

Antibiotic Resistance Market: By Region

On the basis of region, the global antibiotic resistance market is segmented into North America, Europe, Asia Pacific, Middle East Africa and Central & South America. The North America antibiotic resistance market is expected to dominate the global market. Numerous drug launches in the market and high treatment cost are supplementing the growth of the regional market. The availability of better medical facilities in the U.S and increasing healthcare expenditure are some of the major factors driving the market growth in the region. The Asia Pacific region is expected to grow at a high CAGR during the forecast period. High prevalence of bacterial infection in countries such as India and China are driving the market growth in the region.

Antibiotic Resistance Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase antibiotic resistance. The key end-users of the markets are Chang Gung Memorial Hospital and Mayo Clinic, among others.

Antibiotic Resistance Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Antibiotic Resistance Market: Share & Competitor Analysis

Some of the key players operating in the antibiotic resistance market are Basilea Pharmaceutica Ltd., Melinta Therapeutics, Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, Inc., Wockhardt therapeutics, Entasis Therapeutics, PARATEK Therapeutics, and Seres Therapeutics, Inc., Merck & Co. Inc., Novartis AG, Johnson and Johnson, Pfizer Inc., BioFlim Pharma, among others. 

Please note: This is not an exhaustive list of companies profiled in the report.

  • In April 2020, Theravance Biopharma, Inc. announced the launch of the first subject dosed in phase 1 study of TD-0903, in the development for the treatment of hospitalized patients with acute lung injury caused by COVID-19
  • In February 2020, Basilea Pharmaceutica Ltd. entered into an agreement with Pfizer and launched the antifungal-isavuconazole in Australia

Antibiotic Resistance Market: By Disease

  1. Introduction  
    1. Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million) 
  2. Complicated Urinary Tract Infection (cUTI)    
    1. Complicated Urinary Tract Infection (cUTI) : Antibiotic Resistance Market, 2020-2026 (USD Million)
  3. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    1. Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Antibiotic Resistance Market, 2020-2026 (USD Million)
  4. Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)    
    1. Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP): Antibiotic Resistance Market, 2020-2026 (USD Million)
  5. Community Acquired Bacterial Pneumonia (CABP)   
    1. Community Acquired Bacterial Pneumonia (CABP): Antibiotic Resistance Market, 2020-2026 (USD Million)
  6. Complicated Intra-Abdominal Infections (cIAI)          
    1. Complicated Intra-Abdominal Infections (cIAI): Antibiotic Resistance Market, 2020-2026 (USD Million)
  7. Clostridium difficile infections (CDI)  
    1. Clostridium difficile infections (CDI): Antibiotic Resistance Market, 2020-2026 (USD Million)
  8. Blood Stream Infections (BSI)
    1. Blood Stream Infections (BSI): Antibiotic Resistance Market, 2020-2026 (USD Million)
  9. Others
    1. Others: Antibiotic Resistance Market, 2020-2026 (USD Million)

Antibiotic Resistance Market: By Drug Class

  1. Introduction  
    1. Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)         
  2. Lipoglycopeptides     
    1. Lipoglycopeptides: Antibiotic Resistance Market, 2020-2026 (USD Million)  
  3. Oxazolidinones          
    1. Oxazolidinones: Antibiotic Resistance Market, 2020-2026 (USD Million)
  4. Cephalosporins         
    1. Cephalosporins: Antibiotic Resistance Market, 2020-2026 (USD Million)
  5. Tetracyclines 
    1. Tetracyclines: Antibiotic Resistance Market, 2020-2026 (USD Million)
  6. Combination 
    1. Combination: Antibiotic Resistance Market, 2020-2026 (USD Million)
  7. Others
    1. Others: Antibiotic Resistance Market, 2020-2026 (USD Million)

Antibiotic Resistance Market: By Pathogen

  1. Introduction  
    1. Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)
  2. Acinetobacter baumannii (Carbapenem-Resistant)  
    1. Acinetobacter baumannii (Carbapenem-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)      
  3. Pseudomonas aeruginosa (Carbapenem-Resistant) 
    1. Pseudomonas aeruginosa (Carbapenem-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)
  4. Staphylococcus Aureus (Methicillin-Resistant)          
    1. Staphylococcus Aureus (Methicillin-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)
  5. E. coli/K. pneumoniae (Carbapenem-Resistant)       
    1. E. coli/K. pneumoniae (Carbapenem-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)
  6. Streptococcus pneumoniae (Penicillin-Non-Susceptible)       
    1. Streptococcus pneumoniae (Penicillin-Non-Susceptible): Antibiotic Resistance Market, 2020-2026 (USD Million)
  7. Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)         
    1. Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)
  8. Enterococcus faecium (Vancomycin-Resistant)         
    1. Enterococcus faecium (Vancomycin-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)
  9. Haemophilus Influenzae (Ampicillin-Resistant)         
    1. Haemophilus Influenzae (Ampicillin-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

Antibiotic Resistance Market: By Region

  1. Introduction  
    1. Global Antibiotic Resistance Market, Regional Analysis, 2020-2026 (USD Million)    
  2. North America
    1. North America Antibiotic Resistance Market, Regional Analysis, 2020-2026 (USD Million)   
      1. By Disease     
        1. North America Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)          
      2. By Drug Class 
        1. North America Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)          
      3. By Pathogen   
        1. North America Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)          
      4. By Country      
        1. U.S      
          1. By Disease     
            1. U.S. Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. U.S. Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. U.S. Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        2. Canada.          
          1. By Disease     
            1. Canada Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Canada Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. Canada Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        3. Mexico
          1. By Disease     
            1. Mexico Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Mexico Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. Mexico Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
  3. Europe           
    1. Europe Antibiotic Resistance Market, Regional Analysis, 2020-2026 (USD Million)   
      1. By Disease     
        1. Europe Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million) 
      2. By Drug Class 
        1. Europe Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)          
      3. By Pathogen   
        1. Europe Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)
      4. By Country      
        1. Germany        
          1. By Disease     
            1. Germany Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Germany Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. Germany Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        2. UK       
          1. By Disease     
            1. UK Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. UK Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. UK Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        3. France
          1. By Disease     
            1. France Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. France Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. France Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        4. Italy    
          1. By Disease     
            1. Italy Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Italy Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. Italy Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
  4. Asia Pacific   
    1. Asia Pacific Antibiotic Resistance Market, Regional Analysis, 2020-2026 (USD Million)        
      1. By Disease     
        1. Asia Pacific Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)          
      2. By Drug Class 
        1. Asia Pacific Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)                      
      3. By Pathogen   
        1. Asia Pacific Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)          
      4. By Country      
        1. China  
          1. By Disease     
            1. China Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. China Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. China Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        2. Japan  
          1. By Disease     
            1. Japan Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Japan Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. Japan Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        3. India   
          1. By Disease     
            1. India Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. India Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. India Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
        4. South Korea   
          1. By Disease     
            1. South Korea Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. South Korea Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)        
          3. By Pathogen   
            1. South Korea Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)
        5. Rest Of Apac  
          1. By Disease     
            1. Rest Of Apac, Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Rest Of Apac Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)        
          3. By Pathogen   
            1. Rest Of Apac Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)
  5. Central & South America      
    1. Central & South America Antibiotic Resistance Market, Regional Analysis, 2020-2026 (USD Million)   
      1. By Disease     
        1. Central & South America Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million) 
      2. By Drug Class 
        1. Central & South America Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)             
      3. By Pathogen   
        1. Central & South America Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million) 
      4. By Country      
        1. Brazil  
          1. By Disease     
            1. Brazil Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
          2. By Drug Class 
            1. Brazil Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
          3. By Pathogen   
            1. Brazil Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
    2. Middle East & Africa 
      1. Middle East & Africa Antibiotic Resistance Market, Regional Analysis, 2020-2026 (USD Million)   
        1. By Disease     
          1. Middle East & Africa Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)          
        2. By Drug Class 
          1. Middle East & Africa Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million) 
        3. By Pathogen   
          1. Middle East & Africa Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)          
        4. By Country      
          1. Saudi Arabia   
            1. By Disease     
              1. Saudi Arabia Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
            2. By Drug Class 
              1. Saudi Arabia Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)        
            3. By Pathogen   
              1. Saudi Arabia Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)     
          2. UAE     
            1. By Disease     
              1. UAE Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)     
            2. By Drug Class 
              1. UAE Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     
            3. By Pathogen   
              1. UAE Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)

The global Antibiotic Resistance Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Antibiotic Resistance Market

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Antibiotic Resistance Market.

Antibiotic Resistance Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Antibiotic Resistance Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Antibiotic Resistance Market

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Redline Communications
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Cablel
  • Client of Global Market Estimates - Carbotainer
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Evermore
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - infinium
  • Client of Global Market Estimates - Rusada
  • Client of Global Market Estimates - Shield Scientific
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Atlas
  • Client of Global Market Estimates - Bitumar
  • Client of Global Market Estimates - Hidrostal
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Now-Plastics
  • Client of Global Market Estimates - Playment
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Surestar
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Tension Packaging
  • Client of Global Market Estimates - Toray